1IGR - JenaLib

Asym./Biol. Unit - manually (Jmol Viewer)

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (DOMAINS 1-3)

Authors :   T. P. J. Garrett, N. M. Mckern, M. Lou, M. J. Frenkel, J. D. Bentley, G. O. L T. C. Elleman, L. J. Cosgrove, C. W. Ward

Date :   28 Sep 98 (Deposition) - 27 Sep 99 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.60

Chains :   Asym./Biol. Unit : A

Keywords :   Hormone Receptor, Insulin Receptor Family (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   T. P. Garrett, N. M. Mckern, M. Lou, M. J. Frenkel, J. D. Bentley, G. O. Lovrecz, T. C. Elleman, L. J. Cosgrove, C. W. Ward
Crystal Structure Of The First Three Domains Of The Type-1 Insulin-Like Growth Factor Receptor.
Nature V. 394 395 1998
PubMed-ID: 9690478 | Reference-DOI: 10.1038/28668
(for further references see the PDB file header)

Molecule 1 - INSULIN-LIKE GROWTH FACTOR RECEPTOR 1
	Cellular Location	:	CYTOPLASMIC MEMBRANE
	Chains	:	A
	EC Number	:	2.7.10.1
	Engineered	:	YES
	Expression System	:	CRICETULUS GRISEUS
	Expression System Cellular Location	:	SECRETED
	Expression System Cell Line	:	LEC8
	Expression System Common	:	CHINESE HAMSTER
	Expression System Plasmid	:	PEE14/IGF-1R/462
	Expression System Taxid	:	10029
	Fragment	:	UNP RESIDUES 31-492
	Organ	:	PLACENTA
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Other Details	:	LARGE SCALE CELL CULTURE IN A CELLGEN PLUS BIOREACTOR

		1
Asymmetric/Biological Unit	:	A

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (5, 18)

No.	Name	Count	Type	Full Name
1	BMA	1	Ligand/Ion	BETA-D-MANNOSE
2	FUC	2	Ligand/Ion	ALPHA-L-FUCOSE
3	MAN	1	Ligand/Ion	ALPHA-D-MANNOSE
4	NAG	6	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
5	SO4	8	Ligand/Ion	SULFATE ION

Asymmetric Unit (18, 18)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	GLU A:20 , ASN A:21	BINDING SITE FOR RESIDUE NAG A 479A
02	AC2	SOFTWARE	ASN A:105 , SER A:128 , LEU A:129 , ILE A:130 , LEU A:131 , ASP A:132 , ARG A:222 , FUC A:481B , NAG A:482C , HOH A:532	BINDING SITE FOR RESIDUE NAG A 480A
03	AC3	SOFTWARE	ARG A:222 , HIS A:223 , NAG A:480A , NAG A:482C	BINDING SITE FOR RESIDUE FUC A 481B
04	AC4	SOFTWARE	NAG A:480A , FUC A:481B	BINDING SITE FOR RESIDUE NAG A 482C
05	AC5	SOFTWARE	ASN A:214	BINDING SITE FOR RESIDUE NAG A 483A
06	AC6	SOFTWARE	VAL A:140 , ASN A:284 , TYR A:290 , FUC A:485B , NAG A:486C	BINDING SITE FOR RESIDUE NAG A 484A
07	AC7	SOFTWARE	ILE A:292 , NAG A:484A , NAG A:486C	BINDING SITE FOR RESIDUE FUC A 485B
08	AC8	SOFTWARE	GLY A:141 , ASN A:142 , NAG A:484A , FUC A:485B , BMA A:487D	BINDING SITE FOR RESIDUE NAG A 486C
09	AC9	SOFTWARE	NAG A:486C , MAN A:488E	BINDING SITE FOR RESIDUE BMA A 487D
10	BC1	SOFTWARE	GLU A:147 , BMA A:487D	BINDING SITE FOR RESIDUE MAN A 488E
11	BC2	SOFTWARE	THR A:177 , ASN A:179 , ARG A:180	BINDING SITE FOR RESIDUE SO4 A 493
12	BC3	SOFTWARE	ARG A:245 , PHE A:251	BINDING SITE FOR RESIDUE SO4 A 494
13	BC4	SOFTWARE	ARG A:104 , ASN A:105 , LEU A:206 , GLY A:207 , ARG A:222	BINDING SITE FOR RESIDUE SO4 A 495
14	BC5	SOFTWARE	LYS A:80 , LEU A:81 , ARG A:108	BINDING SITE FOR RESIDUE SO4 A 496
15	BC6	SOFTWARE	ARG A:44 , PRO A:46 , ASN A:72	BINDING SITE FOR RESIDUE SO4 A 497
16	BC7	SOFTWARE	ASN A:237 , TYR A:239 , ARG A:249	BINDING SITE FOR RESIDUE SO4 A 498
17	BC8	SOFTWARE	TRP A:79 , TYR A:224 , ARG A:240	BINDING SITE FOR RESIDUE SO4 A 499
18	BC9	SOFTWARE	ARG A:59 , LYS A:359 , ARG A:361	BINDING SITE FOR RESIDUE SO4 A 500

Asymmetric/Biological Unit

No.	Residues
1	A:3	-	A:22
2	A:120	-	A:148
3	A:152	-	A:175
4	A:162	-	A:181
5	A:185	-	A:194
6	A:189	-	A:200
7	A:201	-	A:209
8	A:205	-	A:218
9	A:221	-	A:230
10	A:234	-	A:246
11	A:252	-	A:273
12	A:277	-	A:291
13	A:294	-	A:298
14	A:302	-	A:323
15	A:425	-	A:458

Asymmetric/Biological Unit

No.	Residues
1	Gly A:4	-	Pro A:5

Asymmetric/Biological Unit (6, 6)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_041424	V	105	L	IGF1R_HUMAN	Unclassified	---	A	V	75	L
2	UniProt	VAR_034891	R	138	Q	IGF1R_HUMAN	Disease (IGF1RES)	121912426	A	R	108	Q
3	UniProt	VAR_034892	K	145	N	IGF1R_HUMAN	Disease (IGF1RES)	121912427	A	K	115	N
4	UniProt	VAR_076247	N	359	Y	IGF1R_HUMAN	Disease (IGF1RES)	---	A	N	329	Y
5	UniProt	VAR_018855	V	388	M	IGF1R_HUMAN	Polymorphism	45445894	A	V	358	M
6	UniProt	VAR_034893	R	437	H	IGF1R_HUMAN	Polymorphism	34516635	A	R	407	H

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric/Biological Unit (1, 1)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	FN3	PS50853	Fibronectin type-III domain profile.	IGF1R_HUMAN	491-609 610-708 735-828 834-927	1	A:467-477 - - -

Asymmetric/Biological Unit (7, 7)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000268035	1a	ENSE00001618814	chr15:99192200-99192904	705	IGF1R_HUMAN	1-32	32	1	A:1-2	2
1.2	ENST00000268035	2	ENSE00000943091	chr15:99250791-99251336	546	IGF1R_HUMAN	32-214	183	1	A:2-184	183
1.3	ENST00000268035	3	ENSE00001320137	chr15:99434554-99434866	313	IGF1R_HUMAN	214-318	105	1	A:184-288	105
1.4	ENST00000268035	4	ENSE00001129109	chr15:99439986-99440134	149	IGF1R_HUMAN	318-368	51	1	A:288-338	51
1.5	ENST00000268035	5	ENSE00001301974	chr15:99442706-99442850	145	IGF1R_HUMAN	368-416	49	1	A:338-386	49
1.6	ENST00000268035	6	ENSE00001129094	chr15:99451914-99452128	215	IGF1R_HUMAN	416-488	73	1	A:386-458	73
1.7	ENST00000268035	7	ENSE00001129087	chr15:99454544-99454670	127	IGF1R_HUMAN	488-530	43	1	A:458-478 (gaps)	34
1.8	ENST00000268035	8	ENSE00001129080	chr15:99456273-99456511	239	IGF1R_HUMAN	530-610	81	0	-	-
1.9	ENST00000268035	9	ENSE00001129073	chr15:99459193-99459360	168	IGF1R_HUMAN	610-666	57	0	-	-
1.10	ENST00000268035	10	ENSE00001129062	chr15:99459901-99460105	205	IGF1R_HUMAN	666-734	69	0	-	-
1.11	ENST00000268035	11	ENSE00001129055	chr15:99465377-99465660	284	IGF1R_HUMAN	734-829	96	0	-	-
1.12	ENST00000268035	12	ENSE00001129044	chr15:99467105-99467241	137	IGF1R_HUMAN	829-874	46	0	-	-
1.13	ENST00000268035	13	ENSE00001311160	chr15:99467754-99467913	160	IGF1R_HUMAN	875-928	54	0	-	-
1.14a	ENST00000268035	14a	ENSE00001318374	chr15:99472787-99472889	103	IGF1R_HUMAN	928-962	35	0	-	-
1.15	ENST00000268035	15	ENSE00001297944	chr15:99473464-99473534	71	IGF1R_HUMAN	962-986	25	0	-	-
1.16	ENST00000268035	16	ENSE00001129013	chr15:99478053-99478282	230	IGF1R_HUMAN	986-1062	77	0	-	-
1.17	ENST00000268035	17	ENSE00001129006	chr15:99478545-99478655	111	IGF1R_HUMAN	1063-1099	37	0	-	-
1.18	ENST00000268035	18	ENSE00001319679	chr15:99482430-99482589	160	IGF1R_HUMAN	1100-1153	54	0	-	-
1.19	ENST00000268035	19	ENSE00001597369	chr15:99486152-99486281	130	IGF1R_HUMAN	1153-1196	44	0	-	-
1.20	ENST00000268035	20	ENSE00001128979	chr15:99491803-99491937	135	IGF1R_HUMAN	1196-1241	46	0	-	-
1.21b	ENST00000268035	21b	ENSE00001316091	chr15:99500290-99507759	7470	IGF1R_HUMAN	1241-1367	127	0	-	-

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:471
 aligned with IGF1R_HUMAN | P08069 from UniProtKB/Swiss-Prot  Length:1367

    Alignment length:491
                                    40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500       510       520 
          IGF1R_HUMAN    31 EICGPGIDIRNDYQQLKRLENCTVIEGYLHILLISKAEDYRSYRFPKLTVITEYLLLFRVAGLESLGDLFPNLTVIRGWKLFYNYALVIFEMTNLKDIGLYNLRNITRGAIRIEKNADLCYLSTVDWSLILDAVSNNYIVGNKPPKECGDLCPGTMEEKPMCEKTTINNEYNYRCWTTNRCQKMCPSTCGKRACTENNECCHPECLGSCSAPDNDTACVACRHYYYAGVCVPACPPNTYRFEGWRCVDRDFCANILSAESSDSEGFVIHDGECMQECPSGFIRNGSQSMYCIPCEGPCPKVCEEEKKTKTIDSVTSAQMLQGCTIFKGNLLINIRRGNNIASELENFMGLIEVVTGYVKIRHSHALVSLSFLKNLRLILGEEQLEGNYSFYVLDNQNLQQLWDWDHRNLTIKAGKMYFAFNPKLCVSEIYRMEEVTGTKGRQSKGDINTRNNGERASCESDVLHFTSTTTSKNRIIITWHRYRPPDYRDLI 521
               SCOP domains d1igra1 A:1-149 Type 1 insulin-like growth factor receptor extracellular domain                                                                      d1igra3 A:150-299 Type 1 insulin-like growth factor receptor Cys-rich domain                                                                          d1igra2 A:300-478 Type 1 insulin-like growth factor receptor extracellular domain                                                                                                                SCOP domains
               CATH domains 1igrA01 A:1-184 24 nucleotide stem-loop, u2 snrnp hairpin iv. U2 a'. Chain A, domain 1                                                                                                  ---------------------------------------1igrA02 A:224-299                                                           1igrA03 A:300-478 24 nucleotide stem-loop, u2 snrnp hairpin iv. U2 a'. Chain A, domain 1                                                                                                         CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .ee...eeee.hhhhhhhhh...ee...eeeeeee..............ee...eeeeeee...hhhhh.....ee........eeeeee..............ee...eeeee...........hhhhhh.hhhhheee...hhhhhh..............eee....eee............hhhhh..............eeeee........eeee..ee....ee.......eee...eeehhhhhhh............eee..eee......eee.......eee.......eeeeeeeeeee..hhhhh......eeeeeeee...........hhhhhh...ee...eeee...............ee.........eeeeee................ee...eeeee.....hhhhhhhhhhhhh......................------------......hhh--------hhh Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------L--------------------------------Q------N---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y----------------------------M------------------------------------------------H------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FN3  PDB: A:467-477             PROSITE
           Transcript 1 (1) 1.-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.3  PDB: A:184-288 UniProt: 214-318                                                                -------------------------------------------------Exon 1.5  PDB: A:338-386 UniProt: 368-416        -----------------------------------------------------------------------Exon 1.7  PDB: A:458-478 (gaps)    Transcript 1 (1)
           Transcript 1 (2) -Exon 1.2  PDB: A:2-184 UniProt: 32-214                                                                                                                                                 -------------------------------------------------------------------------------------------------------Exon 1.4  PDB: A:288-338 UniProt: 318-368          -----------------------------------------------Exon 1.6  PDB: A:386-458 UniProt: 416-488                                --------------------------------- Transcript 1 (2)
                 1igr A   1 EICGPGIDIRNDYQQLKRLENCTVIEGYLHILLISKAEDYRSYRFPKLTVITEYLLLFRVAGLESLGDLFPNLTVIRGWKLFYNYALVIFEMTNLKDIGLYNLRNITRGAIRIEKNADLCYLSTVDWSLILDAVSNNYIVGNKPPKECGDLCPGTMEEKPMCEKTTINNEYNYRCWTTNRCQKMCPSTCGKRACTENNECCHPECLGSCSAPDNDTACVACRHYYYAGVCVPACPPNTYRFEGWRCVDRDFCANILSAESSDSEGFVIHDGECMQECPSGFIRNGSQSMYCIPCEGPCPKVCEEEKKTKTIDSVTSAQMLQGCTIFKGNLLINIRRGNNIASELENFMGLIEVVTGYVKIRHSHALVSLSFLKNLRLILGEEQLEGNYSFYVLDNQNLQQLWDWDHRNLTIKAGKMYFAFNPKLCVSEIYRMEEVTGTKGRQSKGDINTRNNGERASCE------------KEQKLISEE--------DLN 478
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450        |-         - |     475       477 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    459          467     475      476

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "Pfam Domain" information available for 1IGR)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (IGF1R_HUMAN | P08069)

molecular function
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
	GO:0043559	insulin binding	Interacting selectively and non-covalently with insulin, a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
	GO:0005158	insulin receptor binding	Interacting selectively and non-covalently with the insulin receptor.
	GO:0043560	insulin receptor substrate binding	Interacting selectively and non-covalently with any of the insulin receptor substrate (IRS) proteins, adaptor proteins that bind to the transphosphorylated insulin and insulin-like growth factor receptors, are themselves phosphorylated and in turn recruit SH2 domain-containing signaling molecules to form a productive signaling complex.
	GO:0031994	insulin-like growth factor I binding	Interacting selectively and non-covalently with insulin-like growth factor I.
	GO:0005520	insulin-like growth factor binding	Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
	GO:0005010	insulin-like growth factor-activated receptor activity	Combining with insulin-like growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0043548	phosphatidylinositol 3-kinase binding	Interacting selectively and non-covalently with a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004672	protein kinase activity	Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
	GO:0004713	protein tyrosine kinase activity	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0004714	transmembrane receptor protein tyrosine kinase activity	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
	GO:0006955	immune response	Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
	GO:0051389	inactivation of MAPKK activity	Any process that terminates the activity of the active enzyme MAP kinase kinase (MAPKK).
	GO:0008286	insulin receptor signaling pathway	The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
	GO:0048009	insulin-like growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands.
	GO:0043066	negative regulation of apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
	GO:0038083	peptidyl-tyrosine autophosphorylation	The phosphorylation by a protein of one or more of its own tyrosine amino acid residues, or a tyrosine residue on an identical protein.
	GO:0014065	phosphatidylinositol 3-kinase signaling	A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
	GO:0048015	phosphatidylinositol-mediated signaling	A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
	GO:0045740	positive regulation of DNA replication	Any process that activates or increases the frequency, rate or extent of DNA replication.
	GO:0030335	positive regulation of cell migration	Any process that activates or increases the frequency, rate or extent of cell migration.
	GO:0008284	positive regulation of cell proliferation	Any process that activates or increases the rate or extent of cell proliferation.
	GO:0046777	protein autophosphorylation	The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
	GO:0006468	protein phosphorylation	The process of introducing a phosphate group on to a protein.
	GO:0051262	protein tetramerization	The formation of a protein tetramer, a macromolecular structure consisting of four noncovalently associated identical or nonidentical subunits.
	GO:0046328	regulation of JNK cascade	Any process that modulates the frequency, rate or extent of signal transduction mediated by the JNK cascade.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
	GO:0035867	alphav-beta3 integrin-IGF-1-IGF1R complex	A protein complex that consists of an alphav-beta3 integrin complex bound to insulin-like growth factor-1 (IGF-1) and type I insulin-like growth factor receptor (IGF1R). IGF1R is a heterotetramer that consists of two alpha-subunits and two beta-subunits.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0043231	intracellular membrane-bounded organelle	Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0043235	receptor complex	Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		BMA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FUC	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MAN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		SO4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Gly A:4 - Pro A:5	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	1igr
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	IGF1R_HUMAN \| P08069
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	2.7.10.1
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	270450
		Disease Information	:	OMIM

Access by GenAge ID
	0015
		Age Related Information	:	GenAge
	0110
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	IGF1R_HUMAN \| P08069
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

(no "Related Entries Specified in the PDB File" available for 1IGR)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (5, 18)

Sites (18, 18)

SS Bonds (15, 15)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (6, 6)

PROSITE Motifs (1, 1)

Exons (7, 7)

Sequences/Alignments

Classification and Annotation

SCOP Domains (2, 3)

CATH Domains (2, 3)

Pfam Domains (0, 0)

Gene Ontology (41, 41)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File